Champignon Brands Selected as Headline Partner for Prohibition Partners' Upcoming Virtual Psychedelics Symposium Following Wednesday's Bullish Price Action, SHRM Stock Could Be in the Very Early Stages of Another Major... read more →
The Federal Government of Both the U.S. and Canada Have Green-Lit the Burgeoning Psychedelics Industry While Also Placing Extremely High Barriers to Entry Strict Regulations Have Prevented Wannabe Firms from... read more →
Medical Professionals are Beginning to Use Psychedelics to Treat a Host of Mental Disorders Champignon Brands is Growing a Vertically Integrated Psychedelic Drug Company Other Major Competitors Are Using Different... read more →
Psychedelics Stock Champignon Brands Soared 15% Today Officially Breaking Out of its Bullish Chart Formation Bull Pennants Are Continuation Patterns, Indicating SHRM's Current Uptrend is Highly Likely to Continue Shares... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelics industry news stories for the week of March 16th – 22nd, 2020.... read more →
At No Fault of Their Own, Many Equities Are Now Temporarily Undervalued as a Result of the Coronavirus Psychedelics Firm Champignon Brands Set to Buy Back up to 2.41 Million... read more →
Novo Formulations is a Specialty Biotech Firm Currently Working with Ketamine, Anaesthetics and Adaptogenics Champignon Brands Plans to Leverage the Novo Formulations Deal to Pursue Psilocybin and MDMA Formulations Champignon... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelics industry news stories for the week of March 9th – 15th, 2020.... read more →
Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of March 9th – 15th, 2020.... read more →
The Artisan Growers Acquisition Will Allow Champignon Brands' to Continue Accelerating its Vertical Integration Strategy Champignon Also Plans to Create the Most Compelling IP Portfolio, Clinical Pipeline and Drug Development... read more →
